| A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia Y Tan, X Wang, H Song, Y Zhang, R Zhang, S Li, W Jin, S Chen, H Fang, ... Blood, The Journal of the American Society of Hematology 137 (11), 1503-1516, 2021 | 61 | 2021 |
| Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t (8; 21) acute myeloid leukemia Y Li, H Wang, X Wang, W Jin, Y Tan, H Fang, S Chen, Z Chen, K Wang Blood, The Journal of the American Society of Hematology 127 (2), 233-242, 2016 | 61 | 2016 |
| PU. 1 controls the expression of long noncoding RNA HOTAIRM1 during granulocytic differentiation S Wei, M Zhao, X Wang, Y Li, K Wang Journal of hematology & oncology 9, 1-9, 2016 | 54 | 2016 |
| CircSPI1 acts as an oncogene in acute myeloid leukemia through antagonizing SPI1 and interacting with microRNAs X Wang, P Jin, Y Zhang, K Wang Cell death & disease 12 (4), 297, 2021 | 28 | 2021 |
| Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia P Jin, Q Jin, X Wang, M Zhao, F Dong, G Jiang, Z Li, J Shen, W Zhang, ... Clinical Cancer Research 28 (18), 4033-4044, 2022 | 8 | 2022 |
| Repression of CDKN2C caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia X Wang, Y Tan, Y Li, J Li, W Jin, K Wang Frontiers of Medicine 10, 420-429, 2016 | 5 | 2016 |
| Mutant U2AF1-induced mis-splicing of mRNA translation genes confers resistance to chemotherapy in acute myeloid leukemia P Jin, X Wang, Q Jin, Y Zhang, J Shen, G Jiang, H Zhu, M Zhao, D Wang, ... Cancer Research 84 (10), 1583-1596, 2024 | 4 | 2024 |
| Driver mutation landscape of acute myeloid leukemia provides insights for neoantigen-based immunotherapy P Jin, J Shen, M Zhao, J Yu, W Jin, G Jiang, Z Li, M He, X Liu, S Wu, ... Cancer Letters, 217427, 2024 | | 2024 |
